Clinical Characteristics of Elderly Patients with Refractory Gastroesophageal Reflux Disease

Vakil, 2006, The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus paper, Am J Gastroenterol, 101, 1900, 10.1111/j.1572-0241.2006.00630.x Fass, 2001, Nonerosive reflux disease-current concepts and dilemmas, Am J Gastroenterol, 96, 303, 10.1111/j.1572-0241.2001.03511.x Locke, 1997, Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota, Gastroenterology, 112, 1448, 10.1016/S0016-5085(97)70025-8 Nebel, 1976, Symptomatic gastroesophageal reflux: incidence and precipitating factors, Am J Dig Dis, 21, 953, 10.1007/BF01071906 Pan, 1999, Epidemiology of the symptoms of patients with gastroesophageal reflux disease in Beijing and Shanghai, Chin J Digest, 19, 223 Cicala, 2013, Proton pump inhibitor resistance, the real challenge in gastro-esophageal reflux disease, World J Gastroenterol, 19, 6529, 10.3748/wjg.v19.i39.6529 Soumekh, 2014, Reflux and acid peptic diseases in the elderly, Clin Geriatr Med, 30, 29, 10.1016/j.cger.2013.10.006 Franceschi, 2009, Acid-related disorders in the elderly, Best Pract Res Clin Gastroenterol, 23, 839, 10.1016/j.bpg.2009.10.004 The Gallup Organization, 2000 Fass, 2005, Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease-where next?, Aliment Pharmacol Ther, 22, 79, 10.1111/j.1365-2036.2005.02531.x Van der Velden, 2008, Maintenance treatment for GERD: residual symptoms are associated with psychological distress, Digestion, 77, 207, 10.1159/000143796 El-Serag, 2007, Obesity increases oesophageal acid exposure, Gut, 56, 749, 10.1136/gut.2006.100263 Ayazi, 2009, Obesity and gastroesophageal reflux: quantifying the association between body mass index, esophageal acid exposure, and lower esophageal sphincter status in a large series of patients with reflux symptoms, J Gastrointest Surg, 13, 1440, 10.1007/s11605-009-0930-7 Crowell, 2009, Obesity is associated with increased 48-hours esophageal acid exposure in patients with symptomatic gastroesophageal reflux, Am J Gastroenterol, 104, 553, 10.1038/ajg.2009.5 Blouin, 1999, Pharmacokinetic considerations in obesity, J Pharm Sci, 88, 1, 10.1021/js980173a Jacobson, 2008, Body mass index and the efficacy of acid-mediating agents for GERD, Dig Dis Sci, 53, 2313, 10.1007/s10620-008-0414-8 Barak, 2002, Gastro-oesophageal reflux disease in obesity: pathophysiological and therapeutic considerations, Obes Rev, 3, 9, 10.1046/j.1467-789X.2002.00049.x Huang, 1999, Gastroesophageal reflux: the features in elderly patients, World J Gastroenterol, 5, 421, 10.3748/wjg.v5.i5.421 Amano, 2001, Role of hiatus hernia and gastric mucosal atrophy in the development of reflux esophagitis in the elderly, J Gastroenterol Hepatol, 16, 132, 10.1046/j.1440-1746.2001.02408.x Tutuian, 2010, Adverse effects of drugs on the esophagus, Best Pract Res Clin Gastroenterol, 24, 91, 10.1016/j.bpg.2010.02.005 Rushnak, 1980, Effect of diazepam on the lower esophageal sphincter. A double-blind controlled study, Am J Gastroenterol, 73, 127